DE20211988U1 - New ointment for treating dry and/or inflamed nasal mucosa, comprises synergistic combination of olive, Hippophae rhamnoides and Nigella sativae oils, odorants and ointment base - Google Patents

New ointment for treating dry and/or inflamed nasal mucosa, comprises synergistic combination of olive, Hippophae rhamnoides and Nigella sativae oils, odorants and ointment base

Info

Publication number
DE20211988U1
DE20211988U1 DE20211988U DE20211988U DE20211988U1 DE 20211988 U1 DE20211988 U1 DE 20211988U1 DE 20211988 U DE20211988 U DE 20211988U DE 20211988 U DE20211988 U DE 20211988U DE 20211988 U1 DE20211988 U1 DE 20211988U1
Authority
DE
Germany
Prior art keywords
ointment
percent
weight
sativae
odorants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE20211988U
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE20211988U priority Critical patent/DE20211988U1/en
Publication of DE20211988U1 publication Critical patent/DE20211988U1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon

Abstract

A care and healing ointment (I) for treatment of dry and/or inflamed nasal mucosa comprises: (a) one part olive oil; (b) one part Hippophae rhamnoides oil; (c) one part Nigella sativae oil; (d) odorants; and (e) an ointment base. ACTIVITY : Antiinflammatory. No supporting data given. MECHANISM OF ACTION : Antioxidant; Antiradical.

Description

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßtThe description text was not recorded electronically

Claims (11)

1. Pflege- und Heilsalbe zur Behandlung trockener und/oder ent­ zündeter Nasenschleimhaut, dadurch gekennzeichnet, dass die Salbe einen Anteil Ol. Olivarum, einen Anteil Ol. Hippophae rham­ noides, einen Anteil Ol. Nigellae sativae, Geruchsstoffe und einen Salbengrundstoff aufweist.1. Care and healing ointment for the treatment of dry and / or inflamed nasal mucosa, characterized in that the ointment has a portion of Ol. Olivarum, a portion of Ol. Hippophae rham noides, a portion of Ol. Nigellae sativae, odorants and an ointment base. 2. Salbe nach Anspruch 1, dadurch gekennzeichnet, dass der Anteil Ol. Olivar. etwa zehn Gewichtsprozent der Salbe beträgt.2. Ointment according to claim 1, characterized in that the proportion Ol. Olivar. is about ten percent by weight of the ointment. 3. Salbe nach Anspruch 1 oder 2, dadurch gekennzeichnet, dass der Anteil Ol. Hippophae rhamnoides zehn Gewichtsprozent der Salbe beträgt.3. Ointment according to claim 1 or 2, characterized in that the Proportion of Ol. Hippophae rhamnoides ten percent by weight of the ointment is. 4. Salbe nach Anspruch 1, 2 oder 3, dadurch gekennzeichnet, dass der Anteil Ol. Nigellae sativae etwa acht Gewichtsprozent der Salbe beträgt. 4. Ointment according to claim 1, 2 or 3, characterized in that the Portion of Ol. Nigellae sativae about eight percent by weight of the ointment is.   5. Salbe nach einem der vorhergehenden Ansprüche, dadurch gekenn­ zeichnet, dass sie ölige Geruchsstoffe aufweist.5. Ointment according to one of the preceding claims, characterized indicates that it has oily odors. 6. Salbe nach einem der vorhergehenden Ansprüche, dadurch gekenn­ zeichnet, dass die öligen Geruchsstoffe Ol. Citri beinhalten.6. Ointment according to one of the preceding claims, characterized indicates that the oily fragrances contain Ol. Citri. 7. Salbe nach Anspruch 6, dadurch gekennzeichnet, dass der Anteil Ol. Citri zwei Gewichsprozent der Salbe beträgt.7. ointment according to claim 6, characterized in that the proportion Ol. Citri is two percent by weight of the ointment. 8. Salbe nach einem der vorhergehenden Ansprüche, dadurch gekenn­ zeichnet, dass die öligen Geruchsstoffe Ol. Pini sylvestris beinhalten.8. Ointment according to one of the preceding claims, characterized indicates that the oily fragrances contain Ol. Pini sylvestris. 9. Salbe nach Anspruch 8, dadurch gekennzeichnet, dass der Anteil Ol. Pini sylvestris zwei Gewichtsprozent der Salbe beinhalten.9. ointment according to claim 8, characterized in that the proportion Ol. Pini sylvestris contain two percent by weight of the ointment. 10. Salbe nach einem der vorhergehenden Ansprüche, dadurch gekenn­ zeichnet, dass der Salbengrundstoff Adipis lanae anhydricum aufweist. 10. Ointment according to one of the preceding claims, characterized records that the basic ointment Adipis lanae anhydricum having.   11. Salbe nach einem der vorhergehenden Ansprüche, dadurch gekenn­ zeichnet, dass die Salbe folgende Zusammensetzung aufweist:
zehn Gewichtsprozent Ol. Olivarum, zehn Gewichtsprozent Ol. Hippophae ramnoides, acht Gewichtsprozent Ol. Nigellae sativae, zwei Gewichtsprozent Ol. Citri, zwei Gewichtsprozent Ol. Pini sylvestris und achtundsechzig Gewichtsprozent Adipis lanae anhydricum.11. Ointment according to one of the preceding claims, characterized in that the ointment has the following composition:
ten percent by weight Ol. Olivarum, ten percent by weight Ol. Hippophae ramnoides, eight percent by weight Ol. Nigellae sativae, two percent by weight Ol. Citri, two percent by weight Ol. Pini sylvestris and sixty-eight percent by weight Adipis lanae anhydricum.
DE20211988U 2002-08-03 2002-08-03 New ointment for treating dry and/or inflamed nasal mucosa, comprises synergistic combination of olive, Hippophae rhamnoides and Nigella sativae oils, odorants and ointment base Expired - Lifetime DE20211988U1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE20211988U DE20211988U1 (en) 2002-08-03 2002-08-03 New ointment for treating dry and/or inflamed nasal mucosa, comprises synergistic combination of olive, Hippophae rhamnoides and Nigella sativae oils, odorants and ointment base

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE20211988U DE20211988U1 (en) 2002-08-03 2002-08-03 New ointment for treating dry and/or inflamed nasal mucosa, comprises synergistic combination of olive, Hippophae rhamnoides and Nigella sativae oils, odorants and ointment base

Publications (1)

Publication Number Publication Date
DE20211988U1 true DE20211988U1 (en) 2003-01-16

Family

ID=7973799

Family Applications (1)

Application Number Title Priority Date Filing Date
DE20211988U Expired - Lifetime DE20211988U1 (en) 2002-08-03 2002-08-03 New ointment for treating dry and/or inflamed nasal mucosa, comprises synergistic combination of olive, Hippophae rhamnoides and Nigella sativae oils, odorants and ointment base

Country Status (1)

Country Link
DE (1) DE20211988U1 (en)

Similar Documents

Publication Publication Date Title
BG105880A (en) Compounds useful as anti-inflammatory agents
PE20001032A1 (en) COMPOSITIONS AND METHODS TO TREAT PULMONARY DISEASES
DE60130466D1 (en) ANTIPRURITIC COMPOSITIONS AND WOUND HEALING COMPOSITIONS
ATE525061T1 (en) SOLID SELF-ADHESIVE COMPOSITIONS FOR THE TOPICAL TREATMENT OF DISORDERS OF THE ORAL MUCOSA
DE60233069D1 (en) COMPOSITIONS OF CURCUMA EXTRACTS FOR THE TREATMENT OF NEUROCEREBROVASCULAR DISEASES
ATE355293T1 (en) SUBSTITUTED 7-AZA-(2.2.1)BICYCLOHEPTANES FOR THE TREATMENT OF DISEASES
DE60228761D1 (en) PHARMACEUTICAL COMPOSITION (KIT) CONTAINING DIHYDROPYRIDINONE COMPOUNDS AND A COMPOUND WITH IMMUNOMODULATORY (OR ANTI-INFLAMMATORY) EFFECT AND ITS USE
BR9914044A (en) tetrahydropyride esters
ES2169127T3 (en) NEW CARBAMATES AND UREAS AS MODIFIERS OF THE MULTI-FARMACO RESISTANCE.
ATE277929T1 (en) IMMUNOSUPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES
DE60141636D1 (en) PHOSPHOLIPID DERIVATIVES OF VALPROIC ACID AND ITS COMBINATIONS
PT1562954E (en) CCR1 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DEMANDING DISEASE I.A.
DE69519577T2 (en) PREDNISOLON METAL SULFOBENZOATE COMPOSITION FOR TREATING INFLAMMATORY DISEASE OF THE COLON
EA199900542A1 (en) COMPOUNDS OF SULPHONIC ACID OR SULPHONYLAMINO-N- (HETEROARALKYL) -ASAGHETHROCYCLOSYME
DK1077941T3 (en) Compounds with growth hormone releasing properties
ATE469907T1 (en) TRIPTOLIDE ANALOGUES FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND INFLAMMATION
DK1032556T3 (en) Pharmaceutically active compounds and methods of use
HRP20050579B1 (en) New synergistic combination comprising roflumilast and formoterol
WO2004082706A3 (en) Ifn-beta alone or in combination with other medicaments for treating alzheimer's disease and demens disorders
DE69105767D1 (en) Bilobalid-phospholipid complexes, their application and compositions containing them.
ATE271861T1 (en) USE OF NMDA ANTAGONISTS AND/OR SODIUM CHANNEL ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
DE20203549U1 (en) Care and healing ointment for the treatment of dry or inflamed nasal mucosa
DE20211988U1 (en) New ointment for treating dry and/or inflamed nasal mucosa, comprises synergistic combination of olive, Hippophae rhamnoides and Nigella sativae oils, odorants and ointment base
DE59900286D1 (en) USE OF SPHINGOSIN-1-PHOSPHATE, SPHINGOSIN-1-PHOSPHATE DERIVATIVES AND / OR THEIR MIXTURES FOR THE TREATMENT OF INFLAMMABLE SKIN DISEASES
DE69804597D1 (en) OIL FOR TREATMENT OF BURNS AND OTHER SKIN DISEASES

Legal Events

Date Code Title Description
R086 Non-binding declaration of licensing interest
R207 Utility model specification

Effective date: 20030220

R156 Lapse of ip right after 3 years

Effective date: 20060301